eXoZymes provides first quarter 2025 and NCTx subsidiary update at 5PM EST today
press releaseinvestor
eXoZymes provides first quarter 2025 and NCTx subsidiary update at 5PM EST todayMay 12, 2025
eXoZymes to host first quarter 2025 and subsidiary NCTx update on Monday May 12, 2025, at 5PM EST
press releaseinvestor
eXoZymes to host first quarter 2025 and subsidiary NCTx update on Monday May 12, 2025, at 5PM ESTMay 7, 2025
eXoZymes launches subsidiary, NCTx, to unlock a promising compound for gut and liver health
press releaseinvestornutraceuticalsmedicinescience
eXoZymes launches subsidiary, NCTx, to unlock a promising compound for gut and liver healthMay 6, 2025
AI transforming biotechnology: From form with AlphaFold to function with exozymes
investorvideoscience
AI transforming biotechnology: From form with AlphaFold to function with exozymesApril 28, 2025
Dr. Tyler Korman, co-founder and VP of Research at eXoZymes, is excited about the 'exozymes' cover story in GEN Biotechnology, which is freely available as an Open Access paper.
press releaseinvestorvideoscience
GEN Biotechnology cover story: Bringing clarity and precision to the cell-free space by introducing exozymesApril 21, 2025
GEN Biotechnology
sciencepublication
GEN Biotechnology: Exozymes for Biomanufacturing: Toward Clarity and Precision in the Cell-Free Space (cover story)April 17, 2025
Bloomberg TV: Jane King interviews co-founder and VP of Research, Dr. Tyler Korman
investorpress clippingsvideoscience
Bloomberg TV: Jane King interviews co-founder and VP of Research, Dr. Tyler KormanApril 15, 2025
BioClick - an enzyme engineering game-changer
press releaseinvestorscienceARCHIVE
ARCHIVE: BioClick – an enzyme engineering game-changer, launched by eXoZymes and supported by a $300K NIH grantApril 10, 2025
ARCHIVE: World Bio Market Insights: eXoZymes appoints Damien Perriman as Chief Commercial Officer
investorpress clippingsARCHIVE
ARCHIVE: World Bio Market Insights: eXoZymes appoints Damien Perriman as Chief Commercial OfficerApril 3, 2025
ARCHIVE: Transcript: eXoZymes 4th quarter and full Year 2024 update from April 2, 2025
investorARCHIVE
ARCHIVE: Transcript: eXoZymes 4th quarter and full Year 2024 update from April 2, 2025April 3, 2025
Previous page
Page 7 of 12
Next page